nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—HTR2C—choroid plexus—intracranial aneurysm	0.164	0.168	CbGeAlD
Fluphenazine—HTR2A—choroid plexus—intracranial aneurysm	0.0823	0.0841	CbGeAlD
Fluphenazine—CALM1—trigeminal nerve—intracranial aneurysm	0.0683	0.0698	CbGeAlD
Fluphenazine—CALM1—cranial nerve—intracranial aneurysm	0.0487	0.0498	CbGeAlD
Fluphenazine—CALM2—pons—intracranial aneurysm	0.0483	0.0494	CbGeAlD
Fluphenazine—CALM1—pons—intracranial aneurysm	0.0481	0.0492	CbGeAlD
Fluphenazine—HTR2A—trigeminal nerve—intracranial aneurysm	0.0416	0.0425	CbGeAlD
Fluphenazine—HTR2A—vein—intracranial aneurysm	0.0376	0.0384	CbGeAlD
Fluphenazine—HTR2A—cranial nerve—intracranial aneurysm	0.0297	0.0303	CbGeAlD
Fluphenazine—HTR2A—pons—intracranial aneurysm	0.0293	0.03	CbGeAlD
Fluphenazine—CALM2—artery—intracranial aneurysm	0.0253	0.0258	CbGeAlD
Fluphenazine—CALM1—artery—intracranial aneurysm	0.0252	0.0257	CbGeAlD
Fluphenazine—DRD1—brainstem—intracranial aneurysm	0.0167	0.0171	CbGeAlD
Fluphenazine—HTR2A—artery—intracranial aneurysm	0.0153	0.0157	CbGeAlD
Fluphenazine—HTR2C—brainstem—intracranial aneurysm	0.013	0.0133	CbGeAlD
Fluphenazine—HTR1A—brainstem—intracranial aneurysm	0.011	0.0112	CbGeAlD
Fluphenazine—CALM2—brainstem—intracranial aneurysm	0.0108	0.011	CbGeAlD
Fluphenazine—CALM1—brainstem—intracranial aneurysm	0.0107	0.0109	CbGeAlD
Fluphenazine—DRD1—midbrain—intracranial aneurysm	0.0107	0.0109	CbGeAlD
Fluphenazine—DRD2—brainstem—intracranial aneurysm	0.0099	0.0101	CbGeAlD
Fluphenazine—CALM3—medulla oblongata—intracranial aneurysm	0.00956	0.00976	CbGeAlD
Fluphenazine—DRD3—brain—intracranial aneurysm	0.00937	0.00957	CbGeAlD
Fluphenazine—HTR2C—medulla oblongata—intracranial aneurysm	0.00907	0.00927	CbGeAlD
Fluphenazine—HTR6—brain—intracranial aneurysm	0.00902	0.00921	CbGeAlD
Fluphenazine—CALM3—midbrain—intracranial aneurysm	0.00873	0.00892	CbGeAlD
Fluphenazine—HTR2C—midbrain—intracranial aneurysm	0.00829	0.00847	CbGeAlD
Fluphenazine—CALM2—medulla oblongata—intracranial aneurysm	0.0075	0.00767	CbGeAlD
Fluphenazine—CALM1—medulla oblongata—intracranial aneurysm	0.00747	0.00763	CbGeAlD
Fluphenazine—HTR1A—midbrain—intracranial aneurysm	0.00698	0.00713	CbGeAlD
Fluphenazine—CALM2—midbrain—intracranial aneurysm	0.00686	0.00701	CbGeAlD
Fluphenazine—CALM1—midbrain—intracranial aneurysm	0.00683	0.00698	CbGeAlD
Fluphenazine—CALM3—cerebellum—intracranial aneurysm	0.00676	0.0069	CbGeAlD
Fluphenazine—DRD1—brain—intracranial aneurysm	0.00671	0.00685	CbGeAlD
Fluphenazine—HTR2A—brainstem—intracranial aneurysm	0.00653	0.00667	CbGeAlD
Fluphenazine—DRD2—midbrain—intracranial aneurysm	0.00631	0.00644	CbGeAlD
Fluphenazine—CYP2D6—brainstem—intracranial aneurysm	0.00595	0.00608	CbGeAlD
Fluphenazine—CALM3—brain—intracranial aneurysm	0.00549	0.00561	CbGeAlD
Fluphenazine—HTR1A—cerebellum—intracranial aneurysm	0.0054	0.00552	CbGeAlD
Fluphenazine—ADRA2A—medulla oblongata—intracranial aneurysm	0.00535	0.00547	CbGeAlD
Fluphenazine—CALM2—cerebellum—intracranial aneurysm	0.00531	0.00542	CbGeAlD
Fluphenazine—CALM1—cerebellum—intracranial aneurysm	0.00528	0.0054	CbGeAlD
Fluphenazine—CYP2E1—medulla oblongata—intracranial aneurysm	0.00524	0.00535	CbGeAlD
Fluphenazine—HTR2C—brain—intracranial aneurysm	0.00521	0.00532	CbGeAlD
Fluphenazine—ADRA2A—midbrain—intracranial aneurysm	0.00489	0.005	CbGeAlD
Fluphenazine—DRD2—cerebellum—intracranial aneurysm	0.00488	0.00498	CbGeAlD
Fluphenazine—HTR2A—medulla oblongata—intracranial aneurysm	0.00455	0.00465	CbGeAlD
Fluphenazine—HTR1A—brain—intracranial aneurysm	0.00439	0.00448	CbGeAlD
Fluphenazine—CALM2—brain—intracranial aneurysm	0.00431	0.0044	CbGeAlD
Fluphenazine—CALM1—brain—intracranial aneurysm	0.00429	0.00438	CbGeAlD
Fluphenazine—HTR2A—midbrain—intracranial aneurysm	0.00416	0.00425	CbGeAlD
Fluphenazine—DRD2—brain—intracranial aneurysm	0.00396	0.00405	CbGeAlD
Fluphenazine—ADRA2A—cerebellum—intracranial aneurysm	0.00378	0.00387	CbGeAlD
Fluphenazine—CYP2E1—cerebellum—intracranial aneurysm	0.0037	0.00378	CbGeAlD
Fluphenazine—HTR2A—cerebellum—intracranial aneurysm	0.00322	0.00329	CbGeAlD
Fluphenazine—HRH1—brain—intracranial aneurysm	0.00313	0.0032	CbGeAlD
Fluphenazine—ADRA2A—brain—intracranial aneurysm	0.00307	0.00314	CbGeAlD
Fluphenazine—CYP2E1—brain—intracranial aneurysm	0.00301	0.00307	CbGeAlD
Fluphenazine—ABCB1—medulla oblongata—intracranial aneurysm	0.00298	0.00305	CbGeAlD
Fluphenazine—CYP2D6—cerebellum—intracranial aneurysm	0.00293	0.003	CbGeAlD
Fluphenazine—ABCB1—midbrain—intracranial aneurysm	0.00273	0.00279	CbGeAlD
Fluphenazine—HTR2A—brain—intracranial aneurysm	0.00261	0.00267	CbGeAlD
Fluphenazine—CYP2D6—brain—intracranial aneurysm	0.00238	0.00243	CbGeAlD
Fluphenazine—ABCB1—cerebellum—intracranial aneurysm	0.00211	0.00215	CbGeAlD
Fluphenazine—ABCB1—brain—intracranial aneurysm	0.00171	0.00175	CbGeAlD
Fluphenazine—DRD1—Signaling Pathways—STARD13—intracranial aneurysm	0.000122	0.00574	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—STARD13—intracranial aneurysm	0.000121	0.00566	CbGpPWpGaD
Fluphenazine—HTR1A—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000116	0.00544	CbGpPWpGaD
Fluphenazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.000116	0.00544	CbGpPWpGaD
Fluphenazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.000116	0.00543	CbGpPWpGaD
Fluphenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000116	0.00542	CbGpPWpGaD
Fluphenazine—HTR2C—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000115	0.00541	CbGpPWpGaD
Fluphenazine—DRD3—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000114	0.00535	CbGpPWpGaD
Fluphenazine—CALM3—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.000106	0.00498	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—STARD13—intracranial aneurysm	0.000105	0.00493	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—STARD13—intracranial aneurysm	0.000105	0.00491	CbGpPWpGaD
Fluphenazine—CALM2—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.000103	0.00482	CbGpPWpGaD
Fluphenazine—CALM1—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.000103	0.00482	CbGpPWpGaD
Fluphenazine—HTR6—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000102	0.0048	CbGpPWpGaD
Fluphenazine—DRD2—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000102	0.00478	CbGpPWpGaD
Fluphenazine—ADRA2A—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.000101	0.00472	CbGpPWpGaD
Fluphenazine—HTR2A—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.0001	0.0047	CbGpPWpGaD
Fluphenazine—HRH1—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.0001	0.00469	CbGpPWpGaD
Fluphenazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	9.94e-05	0.00466	CbGpPWpGaD
Fluphenazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	9.88e-05	0.00464	CbGpPWpGaD
Fluphenazine—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	9.76e-05	0.00458	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—STARD13—intracranial aneurysm	9.23e-05	0.00433	CbGpPWpGaD
Fluphenazine—CALM3—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	9.17e-05	0.0043	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	9.11e-05	0.00428	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—STARD13—intracranial aneurysm	9.08e-05	0.00426	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—STARD13—intracranial aneurysm	9.06e-05	0.00425	CbGpPWpGaD
Fluphenazine—CALM2—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	8.87e-05	0.00416	CbGpPWpGaD
Fluphenazine—CALM1—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	8.87e-05	0.00416	CbGpPWpGaD
Fluphenazine—DRD1—GPCR ligand binding—EDNRA—intracranial aneurysm	8.8e-05	0.00413	CbGpPWpGaD
Fluphenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	8.72e-05	0.00409	CbGpPWpGaD
Fluphenazine—DRD3—GPCR ligand binding—EDNRA—intracranial aneurysm	8.68e-05	0.00407	CbGpPWpGaD
Fluphenazine—CALM2—Endochondral Ossification—MMP9—intracranial aneurysm	8.65e-05	0.00406	CbGpPWpGaD
Fluphenazine—CALM1—Endochondral Ossification—MMP9—intracranial aneurysm	8.65e-05	0.00406	CbGpPWpGaD
Fluphenazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	8.58e-05	0.00403	CbGpPWpGaD
Fluphenazine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	8.56e-05	0.00402	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—STARD13—intracranial aneurysm	8.26e-05	0.00388	CbGpPWpGaD
Fluphenazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	7.81e-05	0.00366	CbGpPWpGaD
Fluphenazine—HTR1A—GPCR ligand binding—EDNRA—intracranial aneurysm	7.57e-05	0.00355	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—STARD13—intracranial aneurysm	7.54e-05	0.00354	CbGpPWpGaD
Fluphenazine—HTR2C—GPCR ligand binding—EDNRA—intracranial aneurysm	7.53e-05	0.00353	CbGpPWpGaD
Fluphenazine—CALM3—Disease—SLC25A16—intracranial aneurysm	7.46e-05	0.0035	CbGpPWpGaD
Fluphenazine—CALM3—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	7.39e-05	0.00347	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—STARD13—intracranial aneurysm	7.29e-05	0.00342	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—STARD13—intracranial aneurysm	7.29e-05	0.00342	CbGpPWpGaD
Fluphenazine—CALM2—Disease—SLC25A16—intracranial aneurysm	7.22e-05	0.00339	CbGpPWpGaD
Fluphenazine—CALM1—Disease—SLC25A16—intracranial aneurysm	7.22e-05	0.00339	CbGpPWpGaD
Fluphenazine—CALM2—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	7.14e-05	0.00335	CbGpPWpGaD
Fluphenazine—CALM1—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	7.14e-05	0.00335	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by VEGF—NOS3—intracranial aneurysm	6.97e-05	0.00327	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—SLC25A16—intracranial aneurysm	6.85e-05	0.00321	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by VEGF—NOS3—intracranial aneurysm	6.74e-05	0.00316	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by VEGF—NOS3—intracranial aneurysm	6.74e-05	0.00316	CbGpPWpGaD
Fluphenazine—DRD2—GPCR ligand binding—EDNRA—intracranial aneurysm	6.64e-05	0.00312	CbGpPWpGaD
Fluphenazine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	6.61e-05	0.0031	CbGpPWpGaD
Fluphenazine—HTR2A—GPCR ligand binding—EDNRA—intracranial aneurysm	6.54e-05	0.00307	CbGpPWpGaD
Fluphenazine—HRH1—GPCR ligand binding—EDNRA—intracranial aneurysm	6.52e-05	0.00306	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—SLC25A16—intracranial aneurysm	6.29e-05	0.00295	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—SLC25A16—intracranial aneurysm	6.25e-05	0.00293	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—CTSS—intracranial aneurysm	6.1e-05	0.00286	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—SLC25A16—intracranial aneurysm	6.05e-05	0.00284	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—SLC25A16—intracranial aneurysm	6.05e-05	0.00284	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR ligand binding—EDNRA—intracranial aneurysm	5.95e-05	0.00279	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—CTSS—intracranial aneurysm	5.9e-05	0.00277	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—CTSS—intracranial aneurysm	5.9e-05	0.00277	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—CTSS—intracranial aneurysm	5.86e-05	0.00275	CbGpPWpGaD
Fluphenazine—HTR6—GPCR downstream signaling—EDNRA—intracranial aneurysm	5.78e-05	0.00271	CbGpPWpGaD
Fluphenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	5.69e-05	0.00267	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—CTSS—intracranial aneurysm	5.67e-05	0.00266	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—CTSS—intracranial aneurysm	5.67e-05	0.00266	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	5.63e-05	0.00264	CbGpPWpGaD
Fluphenazine—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	5.62e-05	0.00264	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—CTSK—intracranial aneurysm	5.62e-05	0.00264	CbGpPWpGaD
Fluphenazine—CALM3—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	5.49e-05	0.00258	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—CTSK—intracranial aneurysm	5.43e-05	0.00255	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—CTSK—intracranial aneurysm	5.43e-05	0.00255	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—CTSK—intracranial aneurysm	5.39e-05	0.00253	CbGpPWpGaD
Fluphenazine—CALM1—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	5.31e-05	0.00249	CbGpPWpGaD
Fluphenazine—CALM2—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	5.31e-05	0.00249	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—EDNRA—intracranial aneurysm	5.25e-05	0.00246	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—CTSK—intracranial aneurysm	5.22e-05	0.00245	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—CTSK—intracranial aneurysm	5.22e-05	0.00245	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—TIMP1—intracranial aneurysm	5.18e-05	0.00243	CbGpPWpGaD
Fluphenazine—HTR6—GPCR ligand binding—CCL2—intracranial aneurysm	5.04e-05	0.00236	CbGpPWpGaD
Fluphenazine—DRD1—GPCR downstream signaling—EDNRA—intracranial aneurysm	4.97e-05	0.00233	CbGpPWpGaD
Fluphenazine—DRD3—GPCR downstream signaling—EDNRA—intracranial aneurysm	4.91e-05	0.0023	CbGpPWpGaD
Fluphenazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	4.9e-05	0.0023	CbGpPWpGaD
Fluphenazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	4.87e-05	0.00229	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—SLC25A16—intracranial aneurysm	4.74e-05	0.00222	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—TIMP1—intracranial aneurysm	4.73e-05	0.00222	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—CTSB—intracranial aneurysm	4.65e-05	0.00218	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—TIMP1—intracranial aneurysm	4.57e-05	0.00215	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—TIMP1—intracranial aneurysm	4.57e-05	0.00215	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—ASAH1—intracranial aneurysm	4.54e-05	0.00213	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—EDNRA—intracranial aneurysm	4.52e-05	0.00212	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—CTSB—intracranial aneurysm	4.5e-05	0.00211	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—CTSB—intracranial aneurysm	4.5e-05	0.00211	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—CTSB—intracranial aneurysm	4.46e-05	0.00209	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—SLC25A16—intracranial aneurysm	4.46e-05	0.00209	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—EDNRA—intracranial aneurysm	4.46e-05	0.00209	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—NCF1—intracranial aneurysm	4.44e-05	0.00208	CbGpPWpGaD
Fluphenazine—DRD1—GPCR ligand binding—CCL2—intracranial aneurysm	4.34e-05	0.00203	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—CTSB—intracranial aneurysm	4.32e-05	0.00203	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—CTSB—intracranial aneurysm	4.32e-05	0.00203	CbGpPWpGaD
Fluphenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	4.3e-05	0.00202	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—NCF1—intracranial aneurysm	4.3e-05	0.00202	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—NCF1—intracranial aneurysm	4.3e-05	0.00202	CbGpPWpGaD
Fluphenazine—DRD3—GPCR ligand binding—CCL2—intracranial aneurysm	4.28e-05	0.00201	CbGpPWpGaD
Fluphenazine—HTR1A—GPCR downstream signaling—EDNRA—intracranial aneurysm	4.28e-05	0.00201	CbGpPWpGaD
Fluphenazine—HTR2C—GPCR downstream signaling—EDNRA—intracranial aneurysm	4.25e-05	0.002	CbGpPWpGaD
Fluphenazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	4.23e-05	0.00198	CbGpPWpGaD
Fluphenazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	4.22e-05	0.00198	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—ASAH1—intracranial aneurysm	4.17e-05	0.00196	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—ASAH1—intracranial aneurysm	4.14e-05	0.00194	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—ASAH1—intracranial aneurysm	4.01e-05	0.00188	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—ASAH1—intracranial aneurysm	4.01e-05	0.00188	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—EDNRA—intracranial aneurysm	3.88e-05	0.00182	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—EDNRA—intracranial aneurysm	3.86e-05	0.00181	CbGpPWpGaD
Fluphenazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	3.85e-05	0.00181	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—SLC25A16—intracranial aneurysm	3.78e-05	0.00177	CbGpPWpGaD
Fluphenazine—DRD2—GPCR downstream signaling—EDNRA—intracranial aneurysm	3.75e-05	0.00176	CbGpPWpGaD
Fluphenazine—HTR1A—GPCR ligand binding—CCL2—intracranial aneurysm	3.73e-05	0.00175	CbGpPWpGaD
Fluphenazine—HTR2C—GPCR ligand binding—CCL2—intracranial aneurysm	3.71e-05	0.00174	CbGpPWpGaD
Fluphenazine—HTR2A—GPCR downstream signaling—EDNRA—intracranial aneurysm	3.69e-05	0.00173	CbGpPWpGaD
Fluphenazine—HRH1—GPCR downstream signaling—EDNRA—intracranial aneurysm	3.69e-05	0.00173	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—CTSS—intracranial aneurysm	3.55e-05	0.00167	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CTSS—intracranial aneurysm	3.44e-05	0.00161	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CTSS—intracranial aneurysm	3.44e-05	0.00161	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—EDNRA—intracranial aneurysm	3.41e-05	0.0016	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—EDNRA—intracranial aneurysm	3.36e-05	0.00158	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—EDNRA—intracranial aneurysm	3.35e-05	0.00157	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—EDNRA—intracranial aneurysm	3.35e-05	0.00157	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—NCF1—intracranial aneurysm	3.28e-05	0.00154	CbGpPWpGaD
Fluphenazine—DRD2—GPCR ligand binding—CCL2—intracranial aneurysm	3.27e-05	0.00154	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—CTSK—intracranial aneurysm	3.27e-05	0.00154	CbGpPWpGaD
Fluphenazine—HTR2A—GPCR ligand binding—CCL2—intracranial aneurysm	3.22e-05	0.00151	CbGpPWpGaD
Fluphenazine—HRH1—GPCR ligand binding—CCL2—intracranial aneurysm	3.21e-05	0.00151	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CTSK—intracranial aneurysm	3.16e-05	0.00148	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CTSK—intracranial aneurysm	3.16e-05	0.00148	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—ASAH1—intracranial aneurysm	3.14e-05	0.00147	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—EDNRA—intracranial aneurysm	3.1e-05	0.00145	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—EDNRA—intracranial aneurysm	3.05e-05	0.00143	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—AGER—intracranial aneurysm	3e-05	0.00141	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—ASAH1—intracranial aneurysm	2.96e-05	0.00139	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR ligand binding—CCL2—intracranial aneurysm	2.93e-05	0.00137	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—AGER—intracranial aneurysm	2.9e-05	0.00136	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—AGER—intracranial aneurysm	2.9e-05	0.00136	CbGpPWpGaD
Fluphenazine—CALM3—Disease—CST3—intracranial aneurysm	2.86e-05	0.00134	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—NCF1—intracranial aneurysm	2.82e-05	0.00133	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—NCF1—intracranial aneurysm	2.79e-05	0.00131	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—EDNRA—intracranial aneurysm	2.78e-05	0.00131	CbGpPWpGaD
Fluphenazine—CALM1—Disease—CST3—intracranial aneurysm	2.77e-05	0.0013	CbGpPWpGaD
Fluphenazine—CALM2—Disease—CST3—intracranial aneurysm	2.77e-05	0.0013	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—CTSB—intracranial aneurysm	2.71e-05	0.00127	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—NCF1—intracranial aneurysm	2.69e-05	0.00126	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—EDNRA—intracranial aneurysm	2.69e-05	0.00126	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—EDNRA—intracranial aneurysm	2.69e-05	0.00126	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—EDNRA—intracranial aneurysm	2.67e-05	0.00125	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—EDNRA—intracranial aneurysm	2.63e-05	0.00123	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CTSB—intracranial aneurysm	2.62e-05	0.00123	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CTSB—intracranial aneurysm	2.62e-05	0.00123	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—NCF1—intracranial aneurysm	2.61e-05	0.00122	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—NCF1—intracranial aneurysm	2.61e-05	0.00122	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—CCL2—intracranial aneurysm	2.58e-05	0.00121	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ASAH1—intracranial aneurysm	2.51e-05	0.00118	CbGpPWpGaD
Fluphenazine—CALM3—Disease—NCF1—intracranial aneurysm	2.49e-05	0.00117	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—NCF1—intracranial aneurysm	2.43e-05	0.00114	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—NCF1—intracranial aneurysm	2.42e-05	0.00113	CbGpPWpGaD
Fluphenazine—CALM2—Disease—NCF1—intracranial aneurysm	2.41e-05	0.00113	CbGpPWpGaD
Fluphenazine—CALM1—Disease—NCF1—intracranial aneurysm	2.41e-05	0.00113	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—NOS3—intracranial aneurysm	2.34e-05	0.0011	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—EDNRA—intracranial aneurysm	2.29e-05	0.00108	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—EDNRA—intracranial aneurysm	2.28e-05	0.00107	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—CCL2—intracranial aneurysm	2.22e-05	0.00104	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—CCL2—intracranial aneurysm	2.2e-05	0.00103	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NCF1—intracranial aneurysm	2.13e-05	0.001	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—NOS3—intracranial aneurysm	2.13e-05	0.001	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NCF1—intracranial aneurysm	2.1e-05	0.000985	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NCF1—intracranial aneurysm	2.09e-05	0.000982	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—NOS3—intracranial aneurysm	2.06e-05	0.000967	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—NOS3—intracranial aneurysm	2.06e-05	0.000967	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—EDNRA—intracranial aneurysm	2.01e-05	0.000945	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—EDNRA—intracranial aneurysm	1.98e-05	0.00093	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—EDNRA—intracranial aneurysm	1.98e-05	0.000928	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—CCL2—intracranial aneurysm	1.91e-05	0.000898	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NCF1—intracranial aneurysm	1.91e-05	0.000896	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—CCL2—intracranial aneurysm	1.9e-05	0.000893	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—EDNRA—intracranial aneurysm	1.8e-05	0.000846	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—AGER—intracranial aneurysm	1.75e-05	0.00082	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NCF1—intracranial aneurysm	1.74e-05	0.000817	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—AGER—intracranial aneurysm	1.69e-05	0.000793	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—AGER—intracranial aneurysm	1.69e-05	0.000793	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NCF1—intracranial aneurysm	1.68e-05	0.000791	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NCF1—intracranial aneurysm	1.68e-05	0.000791	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—CCL2—intracranial aneurysm	1.68e-05	0.000788	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—CCL2—intracranial aneurysm	1.65e-05	0.000776	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—CCL2—intracranial aneurysm	1.65e-05	0.000774	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—EDNRA—intracranial aneurysm	1.64e-05	0.000772	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—EDNRA—intracranial aneurysm	1.59e-05	0.000747	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—EDNRA—intracranial aneurysm	1.59e-05	0.000747	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—CCL2—intracranial aneurysm	1.53e-05	0.000716	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—CCL2—intracranial aneurysm	1.5e-05	0.000706	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—CCL2—intracranial aneurysm	1.37e-05	0.000644	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—NOS3—intracranial aneurysm	1.36e-05	0.000639	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—CCL2—intracranial aneurysm	1.33e-05	0.000623	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—CCL2—intracranial aneurysm	1.33e-05	0.000623	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—CCL2—intracranial aneurysm	1.31e-05	0.000617	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—CCL2—intracranial aneurysm	1.3e-05	0.000609	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—NOS3—intracranial aneurysm	1.17e-05	0.00055	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—NOS3—intracranial aneurysm	1.16e-05	0.000542	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CCL2—intracranial aneurysm	1.13e-05	0.00053	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CCL2—intracranial aneurysm	1.12e-05	0.000528	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—MMP9—intracranial aneurysm	1.09e-05	0.000512	CbGpPWpGaD
Fluphenazine—CALM3—Disease—NOS3—intracranial aneurysm	1.03e-05	0.000484	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—NOS3—intracranial aneurysm	1.01e-05	0.000473	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—NOS3—intracranial aneurysm	1e-05	0.00047	CbGpPWpGaD
Fluphenazine—CALM2—Disease—NOS3—intracranial aneurysm	9.98e-06	0.000468	CbGpPWpGaD
Fluphenazine—CALM1—Disease—NOS3—intracranial aneurysm	9.98e-06	0.000468	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CCL2—intracranial aneurysm	9.92e-06	0.000466	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CCL2—intracranial aneurysm	9.76e-06	0.000458	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CCL2—intracranial aneurysm	9.74e-06	0.000457	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—NOS3—intracranial aneurysm	9.47e-06	0.000444	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—MMP9—intracranial aneurysm	9.4e-06	0.000441	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—MMP9—intracranial aneurysm	9.27e-06	0.000435	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCL2—intracranial aneurysm	8.88e-06	0.000417	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NOS3—intracranial aneurysm	8.84e-06	0.000415	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NOS3—intracranial aneurysm	8.7e-06	0.000408	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—NOS3—intracranial aneurysm	8.7e-06	0.000408	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NOS3—intracranial aneurysm	8.68e-06	0.000407	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—NOS3—intracranial aneurysm	8.64e-06	0.000405	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—NOS3—intracranial aneurysm	8.36e-06	0.000392	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—NOS3—intracranial aneurysm	8.36e-06	0.000392	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCL2—intracranial aneurysm	8.11e-06	0.00038	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MMP9—intracranial aneurysm	8.08e-06	0.000379	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MMP9—intracranial aneurysm	8.04e-06	0.000377	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NOS3—intracranial aneurysm	7.92e-06	0.000372	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCL2—intracranial aneurysm	7.84e-06	0.000368	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCL2—intracranial aneurysm	7.84e-06	0.000368	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NOS3—intracranial aneurysm	7.22e-06	0.000339	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MMP9—intracranial aneurysm	7.1e-06	0.000333	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NOS3—intracranial aneurysm	6.99e-06	0.000328	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NOS3—intracranial aneurysm	6.99e-06	0.000328	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MMP9—intracranial aneurysm	6.98e-06	0.000328	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MMP9—intracranial aneurysm	6.97e-06	0.000327	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—NOS3—intracranial aneurysm	6.55e-06	0.000307	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MMP9—intracranial aneurysm	6.35e-06	0.000298	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—NOS3—intracranial aneurysm	6.17e-06	0.00029	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MMP9—intracranial aneurysm	5.8e-06	0.000272	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MMP9—intracranial aneurysm	5.61e-06	0.000263	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MMP9—intracranial aneurysm	5.61e-06	0.000263	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—NOS3—intracranial aneurysm	5.23e-06	0.000245	CbGpPWpGaD
